Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 12, 2010
The beta3 adrenoceptor agonist, amibegron (SR58611A) counteracts stress-induced behavioral and neurochemical changesAlessandra Tamburella, Vincenzo Micale, Gian Marco Leggio, et al.
The European Journal of Neuroscience|April 5, 2014
Cannabinoid receptor type 1 receptors on GABAergic vs. glutamatergic neurons differentially gate sex-dependent social interest in miceAna Luisa B Terzian, Vincenzo Micale, Carsten T Wotjak
Pharmacological Research|November 26, 2016
Endocannabinoid system in sexual motivational processes: Is it a novel therapeutic horizon?Renata Androvicova, Jiri Horacek, Tibor Stark, et al.
Frontiers in Behavioral Neuroscience|September 3, 2011
The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 ReceptorsAna Luisa Terzian, Filippo Drago, Carsten T Wotjak, et al.
European Journal of Pharmacology|March 20, 2012
The selective norepinephrine reuptake inhibitor atomoxetine counteracts behavioral impairments in trimethyltin-intoxicated ratsAlessandra Tamburella, Vincenzo Micale, Carmen Mazzola, et al.
European Journal of Pharmacology|September 10, 2005
Stressors affect the response of male and female rats to clomipramine in a model of behavioral despair (forced swim test)Daniele Consoli, Julia Fedotova, Vincenzo Micale, et al.
European Journal of Pharmacology|August 3, 2007
Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs?Daniele Consoli, Gian Marco Leggio, Carmen Mazzola, et al.
Toxicology|May 16, 2006
Long-lasting neurotoxicity of prenatal benzene acute exposure in ratsRoberta Lo Pumo, Marcello Bellia, Annarita Nicosia, et al.
Pharmacology & Therapeutics|December 25, 2012
Endocannabinoid system and mood disorders: priming a target for new therapiesVincenzo Micale, Vincenzo Di Marzo, Alexandra Sulcova, et al.
Pharmacological Research|October 16, 2021
Phytocannabinoids and schizophrenia: Focus on adolescence as a critical window of enhanced vulnerability and opportunity for treatmentTibor Stark, Serena Di Martino, Filippo Drago, et al.
Pageof 7